Brussels announces acquisition of 300 million additional vaccine doses from Pfizer and BioNTech

The European Commission announced this Friday the purchase of an additional 300 million doses of the vaccine developed by Pfizer and BioNTech, the first to be approved for marketing and use on the continent, which will double stocks of this vaccine in the EU.

Similar Posts